A multinational randomized, controlled, clinical trial of etoricoxib in the treatment of rheumatoid arthritis [ISRCTN25142273]

BACKGROUND: Etoricoxib is a highly selective COX-2 inhibitor which was evaluated for the treatment of rheumatoid arthritis (RA). METHODS: Double-blind, randomized, placebo and active comparator-controlled, 12-week study conducted at 67 sites in 28 countries. Eligible patients were chronic NSAID user...

Descripción completa

Detalles Bibliográficos
Autores principales: Collantes, Eduardo, Curtis, Sean P, Lee, Ka Wing, Casas, Noemi, McCarthy, Timothy, Melian, Agustin, Zhao, Peng L, Rodgers, Diana B, McCormick, Calogera L, Lee, Michael, Lines, Christopher R, Gertz, Barry J
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2002
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC115849/
https://www.ncbi.nlm.nih.gov/pubmed/12033987
http://dx.doi.org/10.1186/1471-2296-3-10

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC115849/
https://www.ncbi.nlm.nih.gov/pubmed/12033987
http://dx.doi.org/10.1186/1471-2296-3-10

Ejemplares similares